Directionality of information flow through neuronal networks is sustained, at the cellular level, by polarized neurons. However, specific targeting or anchoring motifs, responsible for polarized distribution on the neuronal surface, have only been identified for a few neuronal G-protein-coupled receptors (GPCRs). Here, through mutational and pharmacological modifications of the conformational state of two model GPCRs, the axonal CB1R cannabinoid and the somatodendritic SSTR2 somatostatin receptors, we show important conformation-dependent variations in polarized distribution. Underlying mechanisms include lower efficiency of conformation-dependent GPCR endocytosis in axons, as compared to dendrites, particularly at moderate activation levels, as well as endocytosis-dependent transcytotic delivery of GPCRs from the somatodendritic domain to distal axonal portions, shown by using compartmentalized microfluidic devices. Kinetic modeling predicted that GPCR distribution polarity is highly regulated by steady-state endocytosis, which is conformation dependent and is able to regulate the relative amount of GPCRs targeted to axons, and that axonally polarized distribution is an intermediary phenotype that appears at moderate basal activation levels.
Introduction
Polarized distribution of G-protein-coupled receptors (GPCRs) to one of the main neuronal subdomains -soma, dendrites or axons -has important functional consequences. Considerable effort has been directed toward both classifying GPCRs as pre-or postsynaptic and identifying protein motifs that assure the targeting and anchoring of receptors to presynaptic (axonal) and postsynaptic (somatodendritic) specializations. However, decades of research have yielded the discovery of only a limited number of targeting motifs (reviews in Lasiecka and Winckler, 2011; Winckler and Yap, 2011 ), so precise targeting and anchoring elements have not yet been identified for the majority of neuronal GPCRs. In addition, high-resolution electron microscopy has revealed that many, if not most GPCRs are localized outside of pre-and postsynaptic specializations (Shigemoto et al., 1997; Charara et al., 1999; Fritschy et al., 1999; Meshul and McGinty, 2000; Riad et al., 2000; Muly et al., 2003; Nyiri et al., 2005) . Finally, there is a remarkable and yet unexplained flexibility in distribution phenotypes, so GPCRs may show different polarized distribution patterns depending on the neuronal cell type (Muly, et al., 2003; Dumartin et al., 2007; Nathanson, 2008; , or the neurochemical environment (Dournaud et al., 1998; Decossas et al., 2003; Bernard et al., 2006) . Thus, identification of additional mechanisms regulating sub-neuronal GPCR segregation remains an eminent research objective.
Recent insights into the neuronal cell biology of polarized protein distribution suggest an indirect mechanism of axonal targeting, where after an initial indiscriminate delivery to the whole neuronal surface, selective endocytosis eliminates proteins from the somatodendritic but not axonal surface, either followed by degradation (Garrido et al., 2001) or dendrite-to-axon transcytosis (Wisco et al., 2003) . In both cases, the resulting steady-state distribution is significantly polarized to the axonal surface. In some instances, the initial polarization of the somatodendritic membrane might be reinforced by direct targeting (Yap et al., 2008) , and specific axonal accumulation is also reinforced by specific retention/anchoring (Sampo et al., 2003; Fache et al., 2004; Xu et al., 2006) . In contrast to this default-mode endocytosis, agonist-induced endocytosis of GPCRs is a highly-regulated dynamic cellular process whose most prominent role is the degradation or resensitization/recycling of GPCRs, which are typically desensitized following receptor activation. GPCRs are versatile signaling molecules, displaying a flexible and dynamic three-dimensional structure. Agonist binding modifies the energy landscape and leads to the adoption of an active receptor conformation, leading to activation of intracellular signaling pathways and, ultimately, to endocytosis through the classical clathrin-mediated endocytic pathway (Gainetdinov et al., 2004) . Importantly, chronic activation is often correlated with an elevated intracellular pool of GPCRs in non-polarized cells (Morisset et al., 2000; Whistler et al., 2002; Leterrier et al., 2004; Marion et al., 2004; Morris et al., 2004; Jacquier et al., 2006; Holliday et al., 2007; Mohammad et al., 2007; Chanrion et al., 2008) . In neurons, acute activation of GPCRs also results in endocytosis and recycling, both in vitro and in vivo (Riad, et al., 2000; Bernard, et al., 2006; Scherrer et al., 2006; Lelouvier et al., 2008; von Zastrow, 2010) , but effects of chronic GPCR activation on sub-neuronal distribution have not been investigated yet.
We have previously shown that two axonal GPCRs, the CB1 cannabinoid receptor and the 5-HT1B serotonin receptor are also targeted initially to the somatodendritic plasma membrane and that the subsequent establishment of correct polarized distribution relies on activation-dependent endocytosis by guest on November 4, 2016 http://jmcb.oxfordjournals.org/ Downloaded from (Leterrier et al., 2006; Carrel et al., 2011) . However, we do not know if activated GPCRs are preferentially endocytosed from the somatodendritic plasma membrane as compared to the axonal membrane, and if transcytotic axonal delivery, previously shown for the tyrosine-kinase receptor TrkA (Ascano et al., 2009) , also plays a role in GPCR targeting. More generally, currently we do not know the extent of the activity-dependent plasticity of neuronal GPCR distribution. In the present work, we developed quantitative methods to characterize and model the molecular dynamics of GPCRs at the single-neuron level in order to investigate the role of activity-dependent endocytosis in the regulation of sub-neuronal GPCR targeting.
Results

Mutations of threonine 210 of CB1R lead to highly different polarized distribution patterns
Point-mutations of the T210 residue, which is located in the 3rd transmembrane helix, to alanine (T210A) or isoleucine (T210I) result in changes in the conformational state of CB1Rs, yielding hypoand hyperactive receptor forms, respectively, which display significantly different levels of constitutive activity but preserve responsiveness to agonist and inverse agonist ligands (D'Antona et al., 2006) .
Neuronal expression of the three CB1R forms (wild-type or WT-CB1R, T210A-CB1R and T210I-CB1R), each labeled with the FLAG epitope at the extracellular N-terminus and GFP at the intracellular C-terminus, yields highly different surface distribution patterns ( Figure 1 ). Selective labeling of surface WT-CB1R shows polarized distribution to axons ( Figure 1A and B), as described previously (Coutts et al., 2001; Leterrier, et al., 2006) . The hyperactive T210I-CB1R is largely intracellular, but residual membrane labeling is still polarized to axons. By contrast, the hypoactive T120A-CB1R shows mostly non-polarized distribution over the entire neuronal surface, with clear somatodendritic polarization in a subset of neurons ( Figure 1A ). Quantitative evaluation of surface labeling intensity shows that neurons expressing the three CB1R receptor forms at comparable levels are segregated in three clusters ( Figure 1B) , which display significantly different mean CB1R expression levels on both the axonal and dendritic surface. In axons, the characteristic proximo-distal gradient of WT-CB1R expression on the axonal surface (Coutts, et al., 2001; Leterrier, et al., 2006) is maintained by the residual surface population of T210I-CB1R ( Figure 1C ). In a striking contrast, T210A-CB1R expression shows an inverted gradient, with a progressive diminution of surface labeling along the axon ( Figure 1C ) similar to the distribution of the type-2 somatostatin receptor (SSTR2), a predominantly somatodendritic GPCR (Csaba et al., 2007; Lelouvier, et al., 2008) . Importantly, the remarkable phenotype shift of the T210A-CB1R mutant to a predominantly uniform/somatodendritic distribution was accompanied by the emergence of a novel somatodendritic CB1R functionality. The presynaptic CB1R inhibits neuronal Ca 2+ currents (Pan et al., 1996) , but agonist activation of WT-CB1R ( Supplementary Figure 1 ) and T210I-CB1R (not shown) did not inhibit increase of intracellular calcium in the soma or dendrites, in accordance with the lack of somatodendritic CB1R effects reported previously using brain slices (Freiman et al., 2006) . By contrast, agonist-mediated activation of T210A-CB1R significantly inhibited the entrance of calcium both in the soma and dendrites, and this effect was inhibited by the inverse agonist Rimonabant (Supplementary Figure S1 ). 
T210 mutants function as conformational CB1R isoforms in neurons
In the somatodendritic compartment, WT-CB1R displays a predominantly intracellular localization ( Figure 2 ), T210I-CB1R is almost completely internalized whereas T210A-CB1R displays a more prominent plasma membrane localization (Figure 2A) , similarly to the distribution of T210 mutants in non-polarized HEK-293 cells (D'Antona, et al., 2006) . Consequently, cells expressing the three receptor forms at comparable levels are segregated into 3 clusters, which are significantly different in their surface labeling intensity ( Figure 2B and B'). Remarkably, treatment of T210I-CB1R expressing neurons with the inverse agonist AM281 or treatment of T210A-CB1R expressing neurons with the agonist WIN22,512-2, respectively, resulted in a significant redistribution towards the WT phenotype ( Figure 2A , C and C'), suggesting that distribution of CB1R within the somatodendritic region is well correlated with receptor conformation and that T210-CB1R mutants are true conformational CB1R isoforms, as proposed previously (D'Antona, et al., 2006) .
In conclusion, changes in signaling and in steady-state distribution phenotypes confirm the notion that mutations of threonine 210 to isoleucine (T210I) or alanine (T210A) result in functional GPCR isoforms that closely approximate the active and inactive conformational states of CB1R, respectively. By permanently modulating the conformational state of CB1R, mutations of T210 provide valuable tools to precisely investigate the relation between GPCR activation and sub-neuronal distribution, without putative non-desirable effects often associated with long-term pharmacological treatment.
Activation-dependent endocytosis is highly different between axons and dendrites
The above-reported differential basal distribution of CB1R isoforms may reflect differences in steadystate endocytosis that, in turn, may depend on steady-state activation. Indeed, inverse agonist treatment significantly inhibits spontaneous somatodendritic endocytosis of endogenous CB1R in mature cultured hippocampal neurons (Supplementary Figure S2 ). In order to directly investigate the relationship between the conformational state of CB1R and the relative level of endocytosis in different neuronal sub-domains, we measured sub-domain specific endocytosis of the three CB1R isoforms (Supplementary Figure S2C ; see Supplementary material for experimental details). In neurons expressing WT-CB1R, the number and intensity of labeled endosomes containing recently endocytosed receptors were higher in dendrites than in axons ( Figure 3A ), by almost 400% and 150%, respectively ( Figure 3B ). The cumulative effect of these two parameters led to a more than four-fold difference of total internalized receptors in dendrites as compared to axons. In T210I-CB1R expressing neurons, both parameters were significantly elevated, more prominently in axons than in dendrites, leading to a diminished difference between the total amount of internalized receptors in the two main neuronal sub-domains ( Figure 3A Similar shifts in endosome number and labeling intensity were produced after treatment of WT-CB1R expressing neurons with agonist or inverse agonist ligands, while treatment of T210I-CB1R expressing neurons with an inverse agonist or treatment of T210A-CB1R expressing neurons with an agonist by guest on November 4, 2016 http://jmcb.oxfordjournals.org/ Downloaded from 6 returned these values toward WT levels ( Figure 3B -D). Together, mutational and pharmacological modulation of CB1R yielded a large spectrum of activation levels, resulting in considerable variation of both absolute and relative (dendrite vs. axon) endocytosis levels. Notably, the abundance and labeling intensity of endosomes was always higher in dendrites than in axons. This difference was most pronounced at moderate activation levels and was mainly due to the variability in endosome abundance ( Figure 3B ) and, to a lesser extent, of labeling intensity of individual endosomes ( Figure   3C ). Finally, CB1R activation dependent endocytosis is qualitatively similar between axons and dendrites, with comparable response amplitude and half-maximal effective activation (EC 50(dendrite) =112.6% ± 2.3% and EC 50(axon) =117% ± 2.6%, normalized to basal WT-CB1R activity in HEK-293 cells), showing a constantly negative offset of axonal endocytosis efficiency at all activation levels ( Figure 3E ). In order to investigate whether this negative offset is due to anchoring to scaffolding proteins in the axonal plasma membrane, we analyzed the diffusion of WT-CB1R and T210A-CB1R by fluorescence recovery after photobleaching (FRAP) and compared it with the diffusion of the somatodendritic SSTR2 receptor, which is not expected to be specifically anchored in axons. We observed that the diffusion coefficient and the fraction of mobile receptors are similar for the three receptors (Supplementary Figure S3 ). In addition, diffusion of all receptors was rather rapid, close to the values reported for the GPCR-like bacteriorhodopsin in reconstituted membranes (Cherry et al., 1982) . These results show that CB1R are not anchored to scaffolding proteins in the axonal plasma membrane and suggest that axonal accumulation of CB1R does not rely on specific retention, but rather on reduced endocytic elimination. In conclusion, our results show significant differences in conformational-state dependent endocytosis between axons and dendrites.
Transcytotic delivery of CB1R to the axonal surface
Our results show important sub-neuronal differences of activation-dependent endocytosis. Polarized distribution could be reinforced if, after elimination from the somatodendritic plasma membrane, CB1R
were recycled to the axonal plasma membrane, as reported for various axonal proteins (Lasiecka and Winckler, 2011) . However, to our knowledge, such transcytotic transport of endocytosed GPCRs has not been reported previously. Importantly, axons display anterograde moving endosomes incorporating recently endocytosed WT-CB1R ( Figure 4A and B), as expected for GPCRs recruited in the transcytotic axonal targeting pathway. In order to directly show that CB1Rs, endocytosed from the somatodendritic surface, are inserted to the axonal plasma membrane after transcytotic delivery, we incubated specifically the somatodendritic compartment of living FLAG-WT-CB1R expressing embryonic cortical neurons in a microfluidic device, which allows separation of somatodendritic and axonal domains (Taylor et al., 2005) with anti-FLAG antibodies. After allowing endocytic uptake and transcytotic transport for 4 h at 37°C, the presence of transcytosed anti-FLAG antibodies was detected on the surface of 69.2% of CB1R-expressing axons ( Figure 4C -D, n=13, from two independent experiments). This labeling showed a clear disto-proximal distribution gradient ( Figure 4E ), and was highly diminished after Dynasore-inhibited (80 µM) somatodendritic endocytosis (11%, n=9) ( Figure   4C ). These results unambiguously show that CB1R is transcytosed to the distal axonal surface following somatodendritic endocytosis.
A kinetic model of neuronal GPCR targeting
The sum of the above-reported results indicates that somatodendritic endocytosis and subsequent transcytotic delivery are putative regulators of axonal targeting, as suggested previously for the WT-CB1R (Leterrier, et al., 2006) . In axons, long-range anterograde transport preferentially delivers cargo to distal axonal regions such as growth cones (Craig et al., 1995) or synaptic terminals (Ahmari et al., 2000) , and GPCRs containing specific targeting domains, such as Sushi domain bearing GABA B receptor subtypes, were also reported to arrive directly to distal axonal portions without previous insertion into the plasma membrane (Biermann et al., 2010; Valdes et al., 2012) . However, in order to be able to account for the above reported different distribution gradients of CB1R mutants on the axonal plasma membrane (Figure 1 ), we propose that GPCRs without specific axonal targeting signals reach the axonal plasma membrane through two parallel routes. The first one corresponds to a nonspecific post-Golgi pathway (route 1), in which transport vesicles deliver GPCRs mainly to the somatodendritic plasma membrane but are not actively excluded from the axon. However, these vesicles, which are not specialized for axonal delivery, do not progress very efficiently in axons and are likely to fuse with the plasma membrane of the proximal axon before advancing significantly. lysosomes in hippocampal neurons (Thibault et al., 2012) , and we did not find notable co-localization of intracellular CB1R mutants with the lysosomal marker LAMP1 (Supplementary Figure S4 ). Finally, receptors can freely diffuse on both the somatodendritic and axonal plasma membranes, or they may be "reflected" from the tip of the growth cone and are partially "reflected" from the diffusion barrier at the axonal initial segment (Nakada et al., 2003) .
When the resulting equations (see Supplementary material) are solved at steady state, they yield explicit expression for the number of receptors on the somatodendritic plasma membrane ( ), the number of receptors on the axonal plasma membrane ( ) and the total number of internalized receptors ( ), as a function of the steady-state level of somatodendritic internalization ( ) ( Figure 5A ). This allows plotting the theoretical polarization of GPCR distribution on the neuronal surface ( over ) as a function of . The resulting theoretical curve is a hyperbole ( Figure 5B ).
Interestingly, the plot of the polarized distribution of the three CB1R isoforms against their measured somatodendritic internalization rate is also well fitted (r 2 =0.77) with a hyperbole ( Figure 5C ).
Superposition of the experimental fit with the theoretical curve allows translation of the dimensionless, theoretical steady-state somatodendritic internalization rate ( ) into experimentally measured rates of the somatodendritic endocytosis ( Figure 5C ). This finally allows plotting the effect of somatodendritic endocytosis rate on the distribution of CB1R into the three major sub-neuronal populations: CB1R on the axonal plasma membrane, CB1R on the somatodendritic plasma membrane and internalized CB1R ( Figure 5D ). Strikingly, intermediate levels of steady-state somatodendritic internalization, which correspond approximately to the measured internalization rate of WT-CB1R, result in a majority of CB1R localized on the axonal plasma membrane ( Figure 5D ). Lowering levels of somatodendritic internalization will first result in a balance (uniform distribution) between somatodendritic and axonal CB1R approximately at the measured rate of T210A-CB1R endocytosis, then further decrease results in a predominantly somatodendritic localization. By contrast, increase in somatodendritic internalization will result in a steady decrease of CB1R levels both on the somatodendritic and axonal plasma membrane accompanied by an increase of internalized CB1R, which population becomes dominant approximately at the measured endocytosis rate of T210I-CB1R. In another set of calculations we investigated the influence of the somatodendritic internalization rate on the axonal distribution gradient. At low levels of somatodendritic internalization ( ), the theoretical curve shows a proximo-distal gradient corresponding to a gradual diminution of CB1R expression toward the end of the axon. The gradient is reversed at higher levels of somatodendritic endocytosis (high values), leading to a higher level of CB1R expression in distal parts of the axon. After adjusting a limited number of parameters (see Materials and methods), we were able to fit the theoretical curves to experimental values, measured for the three CB1R forms in neurons selected for having an axon of a 9 approximate length of 600 µm, in order to standardize experimental values. Our results qualitatively
show that the observed concentration gradients of receptors are compatible with our kinetic model ( Figure 5E ). The distribution of the somatodendritic SSTR2, assumed to be transported only via route 1, can also be fitted ( Figure 5E ). It should be noted that the concentration of CB1R and SSTR2 on the first 50-100 µm of the axons is not well captured by the model. Notably, 50-70 µm is the typical scale of the axon initial segment (Nakada, et al., 2003) , which corresponds to a region with highly reduced diffusion of lipids and membrane proteins but in our present model we did not attempt to model GPCR dynamics inside of this special axonal sub-segment.
In 
Polarized CB1R distribution patterns show important activation-dependent plasticity
In order to verify the first theoretical prediction of the above model, we induced persistent and gradual changes in the conformations of the three CB1R forms by using different concentrations of the agonist WIN22,512-2 or the inverse agonist AM281 for 24 h following transfection, the time-scale required to establish polarized axonal distribution in cultured hippocampal neurons (Leterrier, et al., 2006) .
Neurons were then classified based on surface CB1R distribution (Supplementary Figure S5 ), as described previously (Carrel, et al., 2011 ) (see also Supplementary material ). This experimental approach is able to detect population-wide changes in polarized CB1R distribution after modification of the spontaneous endocytosis rate, as demonstrated by expressing a dominant negative (S34N) mutant of the small GTPase Rab5 (Supplementary Figure S6) , which significantly inhibits polarized CB1R distribution in individual neurons (Leterrier, et al., 2006) .
Neurons expressing WT-CB1R, treated either with vehicle (data not shown) or with very low concentrations of agonist or inverse-agonist ligands (1×10 -11 M), mainly displayed the Axonal phenotype (55.89% ± 3.27%, Figure 6A ) while T210I-CB1R expressing neurons belonged mainly to the Internalized phenotype ( Figure 6B ) and those expressing T210A-CB1R displayed a predominantly
Uniform-Somatodendritic or Axonal/Uniform distribution ( Figure 6C ), similarly to non-treated neurons shown on Figure 1A . Interestingly, in addition to these predominant distribution phenotypes, each phenotypic category was represented for every receptor form, indicating an important natural 10 variability of the polarized CB1R distribution pattern in cultured hippocampal neurons. Increasing concentrations of agonist or inverse agonist gradually transformed the WT-CB1R distribution pattern to T210I-CB1R and T210A-CB1R phenotypes, respectively. Inverse agonist treatment of T210I-CB1R expressing neurons or agonist treatment of T210A-CB1R expressing neurons led also to gradual transformations of distribution patterns, allowing an almost complete rescue towards the wild-type phenotype at 1×10 -5 M of AM281 for T210I-CB1R and 1×10 -8 M of WIN22,512 for T210A-CB1R.
Principal component analysis confirmed that pharmacological or mutational modifications of CB1R activation result in highly overlapping distribution patterns ( Figure 6D ). However, there is a notable divergence between the distribution pattern of T210A-CB1R and inverse agonist treated WT-CB1R
(compare black and blue lines at the left-hand side of Figure 6D ). Interestingly, when newlysynthesized WT-CB1R are exported to the plasma membrane in a synchronized manner after Brefeldin A (BFA) treatment (Misumi et al., 1986) in the presence of 1 to 10 µM inverse agonist AM281, the proportion of neurons showing uniform/somatodendritic distribution is 60%-80% after 24 h ( (Leterrier, et al., 2006) , and data not shown), which overlaps well with the T210A phenotype. The reason for this experimental divergence is currently not known.
Taken together, these results confirm the prediction of our model by showing highly elevated activation-dependent plasticity of sub-neuronal distribution. This validates the notion that pharmacologically reversible conformational changes critically regulate CB1R distribution on the neuronal surface.
Prolonged moderate activation leads to axonal redistribution of SSTR2s
In order to verify the second theoretical prediction, we used SSTR2 for three reasons. First, SSTR2
shows little constitutive activity and is mostly localized to the plasma membrane in heterologous expression systems and in neurons. Second, SSTR2 shows a predominantly somatodendritic distribution in adult neurons, but do not appear to be actively excluded from axons as shown by the axonal localization of SSTR2 in certain developmental stages. Third, SSTR2 are efficiently internalized and recycled in neurons following activation by the agonist octreotide (Sarret et al., 1998; Csaba, et al., 2007; Lelouvier, et al., 2008; Le Verche et al., 2009 ).
The previously characterized FLAG-SSTR2-GFP construct (Lelouvier, et al., 2008) was exported to the plasma membrane in a synchronized manner, by using BFA washout, in presence of different concentrations of octreotide. We used the BFA release protocol in order to shorten the incubation period to 12h, because the peptide ligand octreotide may degrade during longer incubation periods at 37°C. As expected, surface SSTR2s displayed a predominantly somatodendritic localization ( Figure   7A ) and high concentrations of octreotide (1×10 -5 M) resulted in a mostly internalized phenotype internalization reaches steady-state CB1R internalization levels in HEK-293 cells ( Figure 7D ).
In conclusion, pharmacological adjustment of the steady-state internalization rate of somatostatin SSTR2 receptors to the level of WT-CB1 partially transforms the natural somatodendritic phenotype of by guest on November 4, 2016 http://jmcb.oxfordjournals.org/ Downloaded from SSTR2 to an axonal phenotype, as predicted by our model. This finding further confirms the notion that pharmacological activation state of GPCRs may be an important determinant of sub-neuronal distribution.
Discussion
By applying quantitative measures of receptor endocytosis and subcellular localization in neurons followed by mathematical modeling, we used an integrative approach to investigate the relationship between the activation state and subcellular distribution of a model GPCR, the type-1 cannabinoid receptor. Our kinetic model reveals the role of the somatodendritic endocytosis rate ( ), which is directly proportional to GPCR activation, to establish experimentally observed distribution phenotypes.
Experimental verification of two non-trivial predictions of the model indicates that distribution of functional GPCRs on the neuronal plasma membrane shows previously unappreciated plasticity. The key determinant of the normal targeting of CB1R to distal axonal portions is the transcytotic targeting pathway. In order to enter this specific transport pathway, receptors must first be retrieved from the somatodendritic plasma membrane by activation-dependent endocytosis. Once delivered to the axonal plasma membrane, the loss due to spontaneous endocytosis is limited because of a difference between dendritic and axonal endocytosis rates, which is more pronounced at moderate activation levels.
According to our model, at low activation levels receptors remain at the site of the initial indiscriminate delivery through route 1 on the somatodendritic and axonal plasma membrane, resulting in predominantly somatodendritic or uniform distribution. In the axon, the lack of efficient anterograde transport results in a gradual diminution of receptor density towards more distal segments, which receptors reach through diffusion in the plasma membrane. The hypo-active T210A-CB1R mutant and SSTR2 show this pattern of distribution. Gradual increase of GPCR activation leads to a gradual decrease of receptors on the somatodendritic membrane, through endocytic elimination. A high proportion of endocytosed receptors enters specific anterograde transport vesicles and is efficiently transported to distal axons. Consequently, receptors will be shifted from the somatodendritic membrane towards distal axonal segments, as shown for the wild-type CB1R or a significant proportion of agonist-activated SSTR2. Finally, further increase of receptor activation leads to endocytic depletion also from the axonal plasma membrane resulting in a predominantly internalized phenotype, as displayed by the hyper-active T210I-CB1R mutant or WT-CB1R and SSTR2 following treatment with high agonist concentrations.
Our model account remarkably well for the observed experimental phenotypes but has several limitations. First, this mechanism is likely important only for the distribution of GPCRs which lack dominant targeting and/or anchoring motifs, provided that these receptors efficiently enter the recycling/transcytotic pathway following activation. Currently we do not know the proportion of directly targeted and/or anchored receptors among the total population of neuronal GPCRs, but methods similar to the FRAP approach used in our study may provide in the future a relatively simple approach to estimate whether interactions with multi-protein complexes may significantly influence steady-state localization of a given GPCR. Second, putative GPCR-activation dependent regulation of the (Leterrier, et al., 2006) and in a recent in vivo study (Thibault, et al., 2012) we were able to qualitatively reproduce previous activationdependent patterns of in vitro CB1R distribution (Leterrier, et al., 2006) . In vivo traffic of the SSTR2 receptor (Csaba, et al., 2007) is also similar to what we reported in vitro (Lelouvier, et al., 2008) .
Collectively, these data suggest at least the qualitative pertinence of our in vitro model.
Dendritic endocytosis
Elimination through spontaneous endocytosis from the somatodendritic plasma membrane is important for the correct, polarized distribution of several neuronal proteins, such as voltage-gated sodium channels, VAMP2, nicotinic acetylcholine receptor alpha 4 subunit, NgCAM, TrkA receptor and Caspr2 (Garrido, et al., 2001; Sampo, et al., 2003; Wisco, et al., 2003; Fache, et al., 2004; Xu, et al., 2006; Ascano, et al., 2009; Bel et al., 2009) . We have previously reported similar endocytic elimination of CB1R from the somatodendritic membrane (Leterrier, et al., 2006) . Notably, we have also found that this constitutive endocytosis was blocked in the presence of the inverse agonist, suggesting that, as observed in non-polarized cells (Leterrier, et al., 2004) , constitutive activation of CB1R was responsible for constitutive endocytosis in neurons. We could also reduce constitutive activation and endocytosis of CB1R by inhibition of DAG-lipase, suggesting that activation is partially due to cellautonomous production of the endocannabinoid 2AG (Turu et al., 2007) . 2AG is synthesized by diacylglycerol (DAG) lipase activity, which is restricted to the dendritic region of adult neurons (Bisogno et al., 2003) . Thus it is likely that newly-synthesized CB1R delivered to the somatodendritic plasma membrane are permanently activated by the presence of the cell-autonomously produced lipid mediator 2AG. Our results have also suggested that steady-state endocytosis is due to mobilization of similar pathways that are activated following activation by agonists, but this notion remained controversial (McDonald et al., 2007; Harkany et al., 2008) . Now we provide further experimental evidence to show that the pharmacological conformational state of CB1Rs is a major regulator of steady-state somatodendritic endocytosis and transcytotic axonal targeting. Possible explanations for the divergent results may be related to the important natural variability of polarized distribution patterns of WT-CB1R in cultured hippocampal neurons ( Figure 6A ) and to the yet unexplained mixed phenotype of WT-CB1R expression following inverse-agonist treatment ( Figure 6D ), which we report here but was absent in T210A-C1BR expressing neurons, similarly to our previous report by a more by guest on November 4, 2016 http://jmcb.oxfordjournals.org/ Downloaded from rigorous BFA release protocol before inverse-agonist treatment (Leterrier, et al., 2006) . Notably, by using two closely related but differentially distributed serotonin receptors, we recently demonstrated also higher constitutive activation and spontaneous endocytosis for the axonal 5-HT 1B R, as compared to the somatodendritic 5-HT 1A R, both in non-neuronal cells and neurons (Carrel, et al., 2011) .
Activation-dependent constitutive endocytosis of 5-HT 1B R is crucial for axonal targeting, since inverse agonist treatment, which prevents constitutive activation, leads to atypical accumulation of newlysynthesized 5-HT 1B Rs on the somatodendritic plasma membrane.
What is the fate of endocytosed somatodendritic CB1R? By using spatial separation of somatodendritic and axonal domains, here we show that at least a portion of endocytosed CB1R is transported anterogradely in axons. Although such anterograde transcytotic transport has been shown for several proteins such as L1/NgCAM (Wisco, et al., 2003; Yap, et al., 2008) , the transferrin receptor (Hemar et al., 1997) and the TrkA neurotrophin receptor (Ascano, et al., 2009) , the molecular composition of putative specific transport intermediates (recently reviewed by (Lasiecka and Winckler, 2011) is not well known yet, so identification of anterograde transcytotic partners for neuronal GPCRs is an important subject of future research.
Axonal endocytosis
CB1R displays a reduced endocytic response in axons at all activation levels as compared to dendrites. This reduced endocytic response to activation may be the result of either a general reduction of endocytosis in axons or of a CB1R-specific reduction of internalization. Indeed, anchoring of CB1R to scaffolding proteins such as CRIP1 was previously proposed to explain axonal accumulation of CB1R (McDonald, et al., 2007; Niehaus et al., 2007) . However, the FRAP-based measurements presented in the present study, as well as a previous report (Mikasova et al., 2008) show that CB1R are relatively free to diffuse in the axonal plasma membrane. Thus, specific interaction through anchoring to scaffolding proteins is unlikely. More probably, reduced internalization of CB1R is caused by a general internalization impairment in axons as compared to dendrites. To our knowledge, such neural sub-domain specific reductions in GPCR endocytosis have not yet been reported. However, it has been shown that the plasma membrane of cultured hippocampal neurons is endocytosed throughout dendrites but only in presynaptic terminals and varicosities in axons (Parton et al., 1992) . In a separate study, plasma membrane endocytosis was estimated to be about 8 times faster in dendrites than in axons of young cultured hippocampal neurons (Ye et al., 2007) . In the present study, in addition to confirming that CB1R are retained in axons due to the reduced endocytic response to constitutive activation (Leterrier, et al., 2006) , we were also able to provide a quantitative insight into the nature of this reduced endocytic response. We found that each investigated activation level yields lower number of endosomes in axons than in dendrites, and that axonal endosomes contain less receptors. However, at higher activation levels the number and labeling intensity of axonal endosomes surpassed steady-state dendritic values and approached activated dendritic values,
showing that the axonal endocytic deficit is not "hard-wired", but rather a quantitative difference between dendritic and axonal endocytic response to a given activation level. The mechanism of this difference is currently unknown, and further research is clearly needed to identify the cause of different endocytosis rates between somatodendritic and axonal GPCRs. What is the physiological relevance of the above findings? Our results suggest a previously unanticipated high functional plasticity for several neuronal GPCRs, predicting that receptors, which are usually highly polarized to one neuronal subdomain, may have significant effects on other parts of the neuron. The sub-neuronal targeting model could be useful to interpret plastic changes in activation-dependent GPCR distribution in pathological contexts, such as epilepsy induced intraneuronal redistribution reported for both CB1R (Karlocai et al., 2011) and SSTR2 (Csaba et al., 2005) . The model also proposes a relatively simple reason -i.e. different levels of steady-state activation -to explain why GPCRs may show different polarized distribution patterns depending on the neuronal cell type (Dumartin, et al., 2007; Nathanson, 2008) or the neurochemical environment (Dournaud, et al., 1998; Bernard, et al., 2006) . Indeed, the intriguing and not yet elucidated redistribution of M2 muscarinic receptors from the somatodendritic plasma membrane to the axonal surface in acetylcholinesterase-deficient mice (Decossas, et al., 2003) , may be explained by the moderate chronic activation of M2 receptors by chronically elevated acetylcholin levels of this experimental strain, in analogy with our in vitro results obtained by moderate chronic activation of the SSTR2 receptor.
In conclusion, our results indicate that activation and targeting of GPCRs may be intimately interconnected in neurons. Accordingly, it is likely that long-term changes in endogenous ligand levels as well as clinical pharmacological treatments may also result in redistribution of several neuronal GPCRs. Thus, besides proposing a previously unappreciated physiological regulatory mechanism, our model also raises the possibility that treatment-induced receptor redistributions may contribute to both wanted and unwanted effects of therapeutic drugs acting on neuronal GPCRs.
Materials and methods
Experimental procedures, model dynamics and suppliers are listed in details in Supplementary material.
Cortical neuronal culture in the microfluidic device
Cortexes of rat embryos were dissected at embryonic day 18. After trypsinization, dissociated cells were electroporated with 5 µg of Flag-CB1R-eGFP plasmid using the Amaxa system (Lonza) and grown in a polydimethylsiloxane two-chamber microfluidic device which allows for separate incubation of the somatodendritic and axonal domains. Dissociated neurons were distributed into the somatodendritic chamber and spontaneously grew axons through the 450 µm long microchannels into the axonal chamber. At DIV7, a mix of mouse monoclonal anti-FLAG antibodies (1/500) and 1% of BSA was added for 4 h to the somatodendritic chamber. Incubation for 4 h at 37°C allowed endocytic uptake and transcytotic transport. To eliminate the possibility of antibody leaking into the axonal chamber, we added a higher volume of medium into the axonal chamber to induce a slow flow through the micro-channels towards the somatodendritic compartment. Before fixation, the axonal compartment was incubated with anti-mouse IgG Alexa-Fluor 568 (1:400) for 10 min at 37°C to reveal transcytosed CB1R. We quantified the proximo-distal distribution profile of transcytosed CB1Rs by 
Kinetic model of neuronal GPCR targeting
The model is depicted in Figure 5A 
